104
Views
9
CrossRef citations to date
0
Altmetric
Original Article

The association of psychosocial factors with nausea and vomiting during pregnancy

, , , &
Pages 17-22 | Received 19 Sep 2006, Accepted 13 Jun 2007, Published online: 07 Jul 2009

References

  • Gadsby R, Barnie-Adshead A M, Jagger C. A prospective study of nausea and vomiting during pregnancy. Br J Gen Pract 1993; 43: 245–248
  • Lacriox R, Eason E, Metzack R. Nausea and vomiting during pregnancy: A prospective study of its frequency, intencity, and patterns of change. Am J Obstet Gynecol 2000; 182(4)931–937
  • American College of Gynecology Practice Bulletin. Nausea and Vomiting in Pregnancy. Obstet Gynecol 2004; 103: 803–814
  • Strong T H. Alternative Therapies of Morning Sickness. Clin Obstet Gynecol 2001; 44(4)653–660
  • Paalberg K M, Vingerhoets A J, Passchier J, Heinen A G, Dekker G A, et al. Psychosocial factors as predictors or maternel well-being and pregnancy-related complaints. J Psychosom Obstet Gynecol 1996; 17: 93–102
  • Chou F H, Lin L L, Cooney A T, Walker L O, Riggs M W. Psychosocial Factors Related to Nausea, Vomiting and Fatigue in Early Pregnancy. J Nurs Scholarsh 2003; 35(2)119–125
  • Katon W J, Ries R K, Bokan J A, Kleinman A. Hyperemesis gravidarum: A biopsychosocial perspective. Int J Psych Medic 1980; 10(2)151–162
  • Mazzotta P, Stewart D, Atanackovic G, Koren G, Magee L A. Psychosocial morbidity among women with nausea and vomiting of pregnancy: prevalence and association with anti-emetic therapy. J Psychosom Obstet Gynecol 2000; 21: 129–136
  • Egen-Lappe V, Hasford J. Durg prescription in pregnancy: anaylsis of a large statutory sickness fund population. Eur J Clin Pharmacol 2004; 60(9)659–666
  • Deutsche Homöopathie-Union. Homöopathisches Repititorium- Arzneimittel-lehre für die tägliche Praxis 2003; 140: 408–412
  • Egen V, Hasfrod J. Drug utilization during Pregnancy – Final Report of the Prospective Study ‘PEGASUS’. Pharmacoepidemiol Drud Saf 2002; 11(S1)29
  • Hasford J. Pegasus: Bayerischer Forschungsverbund Public Health (BFV). München 2002; 13–20
  • Olsen C, Sonergaard C, Thrane N, Nielsen G L, de Jong-van den Berg L, et al. Do Pregnant Women Report Use of Dispensed Medications?. Epidemiology 2001; 12(5)497–501
  • Bakker M K, Jentink J, Vroom F, Van Den Berg P B, De Walle H EK, De Jong-Van Den Berg L TW. Drug prescription patterns before, during and after pregnancy for chronic, occasional and pregnancy-related drugs in the Netherlands. BJOG 2006; 113: 559–568
  • Beyens M N, Guy C, Ratrema M, Ollagnier M. Perscription of Drugs to Pregnant Women in France: the HIMAGE Study. Therapie 2003; 58(6)505–511
  • von Kries R, Toschke M, Koletzko B, Slikker W, Jr. Maternal smoking status during pregnancy and childhood obesity. Am J Epidemiol 2002; 156: 954–961
  • Weigel M M, Weigel R M. The association of history, demographic factors, and alcohol and tobacco consumption with the risk of developing nausea and vomiting in early pregnancy. Am J Epidemiol 1988; 127: 562–570
  • Otto B, Riepl R L, Klosterhalfen S, Enck P. Auton Neurosci. Endocrine correlates of acute nausea and vomiting 2006; 129(1–2)17–21
  • David M, Borde T, Kentenich H. Ist die Hyperemesis gravidarum heute vor allem eine Erkrankung von Migrantinnen?. Geburtsh Frauenheilk 2002; 62: 327–332
  • Strunz-Lehner C, Egen-Lappe V, Hasford J, Janhsen K, Glaeske G. The impact of region, age and social status on drug prescribing during pregnancy. Pharmacoepidemiol. Drug Saf 2004; 13(S1)182
  • Mielk A. Soziale Ungleichheit und Gesundheit: Empierische Ergebnisse, Erklärungsansätze, Interventionsmöglichkeiten. Hans Huber-Verlag, Bern 2000; 64
  • Rodriguez A, Bohlin G, Lindmark G. Symtoms across pregnancy in relation to psychosocial and biomedical factors. Acta Obstet Gynecol Scand 2001; 80: 213–223
  • Jewell D, Young G. Interventions for nausea and vomiting in early pregnancy (Cochrane Review). The Cochrane Library, Issue 2, 2004. John Wiley and Sons, Ltd, ChichesterUK 2004
  • Floer B, Butzlaff M, Koneczny N, Isfort J. Kopfscherzen und Migräne, [cited 2006 June 12]; Available at http//www.evidence.de/Leitlinien/leitlinien-inter/Kopfschmerzen_Start/Kopfschmerzen_Therapie/kopfschmerzen_therapie.html

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.